NCT07310485
Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausal Women
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Start date pushed from Nov 1, 2025 to Feb 1, 2026 Show 4 more changesShow less
- Eligibility criteria expanded, about 11 words
- Trial status changed: Enrolling by Invitation → Completed
- Study completion date changed from estimate of Aug 31, 2026 to May 25, 2026
- Secondary endpoints: details revised at 3 of 3 entries
Notable Primary endpoint(s) modifiedv2 Show 6 more changesShow less
- Eligibility criteria expanded, about 9 words
- Enrollment reduced: 70 → 50 participants
- Primary completion date changed from estimate of Jan 2, 2026 to May 25, 2026
- Study completion pushed from Feb 20, 2026 to Aug 31, 2026
- Secondary endpoints: 1 to 3
- Study description shortened, about 6 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Fold Change From Baseline in FSTL1 Gene Expression
Timeframe: Time Frame: Baseline (Week 0) and End of Intervention (Week 12)
Fold Change From Baseline in TGFB1 Gene Expression
Timeframe: (Week 0) and end of intervention (Week 12)
Secondary (3)
Change From Baseline in the Mean Physical-Symptom Domain Score on the Arabic Premenstrual Syndrome Scale
Change From Baseline in the Mean Psychological-Symptom Domain Score on the Arabic Premenstrual Syndrome Scale
Change From Baseline in the Impairment-of-Functioning Domain Score on the Arabic Premenstrual Syndrome Scale
Arms and interventions
placeboPlacebo comparator
Microcrystalline cellulose (Placebo), taken orally once daily for 12 weeks. The capsule is matched in size, color, and taste to the active phytoestrogen supplement.
Intevention SDG lignansExperimental
Dietary Supplement: SDG lignans phytoestrogen 100 mg SDG (Active Ingredient), taken orally once daily for 12 weeks
Dietary supplements: SDG lignans, Placebo
Sites
1 site in 1 country
- the university of JordanAmman, Amman Governorate, Jordan